DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
27.05.2021 14:45:00
|
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
- Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present on behalf of the company at the William Blair 41st Annual Growth Stock Conference to be held virtually on Tuesday, June 1, 2021 at 12:00pm (CDT). The presentation will be available via live webcast.
The webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005204/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Gewinne in New York: Das macht der S&P 500 am Nachmittag (finanzen.at) | |
02.05.25 |
Pluszeichen in New York: NASDAQ 100 klettert nachmittags (finanzen.at) | |
02.05.25 |
Gute Stimmung in New York: So steht der NASDAQ Composite am Nachmittag (finanzen.at) | |
02.05.25 |
Börse New York: Am Mittag Pluszeichen im NASDAQ Composite (finanzen.at) | |
02.05.25 |
Handel in New York: S&P 500 notiert am Mittag im Plus (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 70,24 | -1,49% |
|